Tuesday, June 11, 2019

Cresco Labs Sees Delay in Origin House Acquisition Due to Antitrust Review

Cresco Labs Provides Update on Origin House Acquisition CHICAGO, June 11, 2019 — (Business Wire) — Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today provided an update on its acquisition (the “Transaction”) of CannaRoyalty Corp. d/b/a Origin
[Read More ...]

Originally posted on Cresco Labs Sees Delay in Origin House Acquisition Due to Antitrust Review via Vic Neufeld Medical Marijuana News

No comments:

Post a Comment